Securities law
Advent Technologies Holdings, Inc. has filed a Current Report with the U.S. Securities and Exchange Commission, disclosing the entry into a purchase agreement with Hudson Global Ventures, LLC. The agreement enables Advent to sell up to $52,000,000 worth of common stock to Hudson over a 24-month term.
Securities law
BiomX Inc. has filed a Form 8-K with the U.S. Securities and Exchange Commission announcing that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Company's Phase 2b study for its drug candidate BX004 in treating Cystic Fibrosis (CF). The FDA
Securities law
A cybersecurity incident has affected Inotiv, Inc.'s systems and data, causing disruptions to certain business operations and potentially impacting the company's financial condition. The company is working to contain, assess, and remediate the incident, although the full scope and nature of the impacts are not yet
Securities law
The law firm Faruqi & Faruqi, LLP is investigating potential claims against Alto Neuroscience, Inc. regarding its initial public offering (IPO) conducted in February 2024 and subsequent stock performance. Investors who suffered losses of over $50,000 in Alto stock are encouraged to contact partner Josh Wilson directly to discuss
Securities law
Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Fiserv, Inc. (NYSE: FI) over alleged false and misleading statements regarding its Clover platform's growth and revenue performance. The firm reminds investors that September 22, 2025, is the deadline to seek the role of
Securities law
Investors who suffered losses in Novo Nordisk's stock between May 7 and July 28, 2025, are reminded of the September 30, 2025, deadline to seek lead plaintiff status in a federal securities class action. The complaint alleges that the company and its executives made false and misleading statements
Securities law
Shareholders who invested in Tesla, Inc. ("Tesla") between April 19, 2023, and June 22, 2025, may be entitled to compensation due to alleged securities fraud. The class action lawsuit claims that Tesla overstated the effectiveness of its autonomous driving technology, which led to regulatory scrutiny and financial losses
Securities law
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ: REPL) following a federal securities class action filed against the Company. The lawsuit alleges that Replimune and its executives violated federal securities laws
Securities law
BioXcel Therapeutics, Inc., a biopharmaceutical company, has received positive preliminary meeting comments from the U.S. Food and Drug Administration (FDA) regarding its planned pre-sNDA meeting scheduled for August 20, 2025. The company is evaluating the feedback and plans to provide an update next week. The meeting is aimed at
Securities law
Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Fiserv, Inc. (NYSE: FI) related to the company's alleged false and misleading statements about its Clover platform revenue growth and gross payment volume (GPV). The investigation is in response to a federal securities class
Securities law
On January 26, 2024, the Toronto Stock Exchange delisted Marathon Gold Corporation's shares, and the company has completed a court-approved plan of arrangement, resulting in its parent company, Calibre Mining Corp., acquiring all of Marathon Gold Corporation's outstanding shares. The Ontario Securities Commission has issued an
Securities law
Singapore-based SUNAC CHINA HOLDINGS LIMITED has proposed a restructuring plan, which includes the release of the company's indebtedness and certain obligations of other entities in the group. The plan involves the distribution of new mandatory convertible bonds (MCBs) to scheme creditors as restructuring consideration. The estimated debt claims,
